Search Results | Showing 1 - 8 of 8 results for "Dr Manny Pohl" |
| | | Industry veteran Dr Manny Pohl is stepping down from the board of small-to-mid cap listed investment company Barrack St Investments effective 30 June 2017. Dr Pohl's boutique Australian equity house, ECP Asset management, founded the LIC in 2014 to ... |
| | | | ECP Asset Management (ECPAM), the investment boutique set up by Hyperion Asset Management founder Dr Manny Pohl, has secured its third institutional mandate and made an addition to its investment team. Sam Byrnes has joined the firm in the newly created ... |
| | | | ... allow us to more closely work with our institutional clients in Sydney and Melbourne," chairman and chief executive Dr Manny Pohl said, adding that the group's flagship strategy, ECP AM EX50, is performing well and funds under management are rising steadily. ... |
| | | | Former Hyperion Asset Management managing director Dr. Manny Pohl has launched a new long only, growth style mid cap equity fund via his new venture, ES Pohl & Co. The EC Pohl & CO Mid Market Opportunities fund will focus on stocks outside the ASX top ... |
| | | | ... excellent vintage for private equity investments, said former Hyperion Asset Management founder and managing director, Dr Manny Pohl. Outstanding opportunities exist at the mid-level of the market, said Pohl, whose new private equity vehicle aims to ... |
| | | | ... has been a Senior Portfolio Manager at Hyperion since 2001 and will be based in the Brisbane office reporting to Dr Manny Pohl, managing director. Gray brings 16 years' experience to the role. Prior to joining Hyperion in 2001, Gray worked as an Investment ... |
| | | | ... quality, predictable companies a significant factor in our decision making process." Hyperion managing director, Dr Manny Pohl, said their style is benchmark insensitive and uses a quantitative based, elimination stock picking process. "We eliminate ... |
| | | | ... implementation of a cap on funds. WHTM will now be called Hyperion Asset Management (Hyperion), and its four key executives, Dr Manny Pohl, Timothy Samway, Mark Arnold, and Joel Grey, have sold down their interest in former parent company Wilson HTM ... |
|